Levofloxacin pharmacokinetics, pharmacodynamics and outcome in multidrug-resistant tuberculosis patients

Eur Respir J. 2019 Apr 18;53(4):1802107. doi: 10.1183/13993003.02107-2018. Print 2019 Apr.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Levofloxacin / pharmacokinetics
  • Levofloxacin / pharmacology*
  • Levofloxacin / therapeutic use*
  • Prospective Studies
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / metabolism

Substances

  • Levofloxacin